Indivi
Indivi is developing digital biomarkers and digital health technologies (DHT) and precision measurements to accelerate neuroscience drug development and personalized care in neurodegenerative and neuroimmune diseases.
Indivi has raised €16M across 1 funding round from 1 investor, most recently a round in Nov 2025. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Basel, Switzerlandindivi.io ↗
Total raised
€16M
€16,156,829
Funding rounds
1
Investors
1
distinct backers
Active since
2025-11
latest 2025-11
Funding by year
EUR raised per yearIndivi — funding by year — interactive chart.
Data table
| Indivi — funding by year | |
|---|---|
| 2025 | €16M |
Signals
High confidenceRaise-next likelihood39
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-11-19 | Other | €16M | Ava Investors | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData